Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$4.29 - $5.97 $184,221 - $256,363
-42,942 Reduced 38.67%
68,099 $308,000
Q4 2023

Feb 01, 2024

SELL
$3.91 - $5.93 $200,031 - $303,372
-51,159 Reduced 31.54%
111,041 $634,000
Q3 2023

Nov 02, 2023

BUY
$4.6 - $7.95 $173,995 - $300,708
37,825 Added 30.41%
162,200 $746,000
Q2 2023

Jul 31, 2023

SELL
$5.66 - $7.59 $11,393 - $15,278
-2,013 Reduced 1.59%
124,375 $803,000
Q1 2023

Jun 27, 2023

BUY
$7.31 - $11.18 $923,896 - $1.41 Million
126,388 New
126,388 $952,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $833M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.